BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36048347)

  • 1. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
    Ichikawa H; Shibutani T; Onoguchi M; Taniguchi Y
    Ann Nucl Med; 2022 Nov; 36(11):941-950. PubMed ID: 36048347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Umeda T; Koizumi M; Fukai S; Miyaji N; Motegi K; Nakazawa S; Takiguchi T
    Ann Nucl Med; 2018 Feb; 32(2):105-113. PubMed ID: 29243019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
    Motegi K; Matsutomo N; Yamamoto T; Koizumi M
    Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
    Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
    BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bone scans in advanced prostate carcinoma using fully automated and semi-automated bone scan index methods.
    Takahashi Y; Yoshimura M; Suzuki K; Hashimoto T; Hirose H; Uchida K; Inoue S; Koizumi K; Tokuuye K
    Ann Nucl Med; 2012 Aug; 26(7):586-93. PubMed ID: 22744807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of
    Oya T; Ichikawa Y; Nakamura S; Tomita Y; Sasaki T; Inoue T; Sakuma H
    Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    Anand A; Morris MJ; Kaboteh R; Båth L; Sadik M; Gjertsson P; Lomsky M; Edenbrandt L; Minarik D; Bjartell A
    J Nucl Med; 2016 Jan; 57(1):41-5. PubMed ID: 26315832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bone single-photon emission computed tomography (SPECT)/CT and bone scintigraphy in assessing knee joints.
    An YS; Park DY; Min BH; Lee SJ; Yoon JK
    BMC Med Imaging; 2021 Mar; 21(1):60. PubMed ID: 33771130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computer program to assess the bone scan index for Tc-99m hydroxymethylene diphosphonate: evaluation of jaw pathologies of patients with bone metastases using SPECT/CT.
    Ogawa R; Ogura I
    Diagn Interv Radiol; 2023 Jan; 29(1):190-194. PubMed ID: 36960615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
    Higashiyama S; Yoshida A; Kawabe J
    Urol Int; 2022; 106(9):963-969. PubMed ID: 35249033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual Comparison of
    Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
    J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
    Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
    Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmented linear correlations between bone scan index and prostate cancer biomarkers, alkaline phosphatase, and prostate specific antigen in patients with a Gleason score ≥7.
    Ebrahim T; Hadebe B; Aldous C; Tinarwo P; Nyakale N
    Medicine (Baltimore); 2022 Jun; 101(25):e29515. PubMed ID: 35758394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
    Mohd Rohani MF; Mat Nawi N; Shamim SE; Wan Sohaimi WF; Wan Zainon WMN; Musarudin M; Said MA; Hashim H
    Ann Nucl Med; 2020 Jan; 34(1):39-48. PubMed ID: 31612417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative [
    Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
    EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.
    Ulmert D; Kaboteh R; Fox JJ; Savage C; Evans MJ; Lilja H; Abrahamsson PA; Björk T; Gerdtsson A; Bjartell A; Gjertsson P; Höglund P; Lomsky M; Ohlsson M; Richter J; Sadik M; Morris MJ; Scher HI; Sjöstrand K; Yu A; Suurküla M; Edenbrandt L; Larson SM
    Eur Urol; 2012 Jul; 62(1):78-84. PubMed ID: 22306323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of Quantitative Bone SPECT/CT Before
    Dittmann H; Kaltenbach S; Weissinger M; Fiz F; Martus P; Pritzkow M; Kupferschlaeger J; la Fougère C
    J Nucl Med; 2021 Jan; 62(1):48-54. PubMed ID: 32444369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.